46% power in study planning? [Study As­sess­ment]

posted by sam – India, 2013-08-02 09:00 (4712 d 19:23 ago) – Posting: # 11160
Views: 30,686

Hi John

❝ If outlier test confirms then one option is to do a rechallenge study -> Run another small study with the questionable subjects along with a few controls.


Will the USFDA accept the data after exclusion of the subjects if the re-dosing confirms the outlier.

Regards

Sam

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
363 visitors (0 registered, 363 guests [including 30 identified bots]).
Forum time: 04:23 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5